Fundraising FoxMarkovian
Venture capitalPre-Seed–Seed · 1 people tracked
Find your way into Markovian
Sign up to find every way you can get introduced to Markovian
- Your email: who you already know at Markovian, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Markovian team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Markovian invests in European deeptech companies at the intersection of scientific IP, early commercial proof and strong founders. It targets IP-heavy startups with European operations, credible early commercial signals and a path to global relevance, concentrating on the Oxford, Cambridge and Munich ecosystems. Focus areas include biology turned into engineering (protein synthesis, therapeutics infrastructure, phage platforms, screening systems), technical software (AI tooling, verification, scientific automation), and hard technology (hardware, EDA, semiconductor tooling, robotics, infrastructure). The firm operates with a long-horizon, concentrated, compounding approach, deploying small high-conviction tickets and co-investing with trusted backers rather than acting like a large institutional fund.
Source: firm website, verified Oct 2, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 5 portfolio companiesDeep Tech ×2Biotech ×1Developer Tools ×1Healthtech ×1Semiconductors ×1
HQs:Germany×1United Kingdom×1
Investments · 5 tracked
founders shown can be your intro pathChipFlow provides curated open-source EDA tools, mixed-signal design workflows and engineering support for integrated circuit (IC) design.
Deep TechDeveloper ToolsSemiconductorsCambridge, GB
Michel Laudes(Founder)in
Co-investorsFontinalis PartnersInMotion VenturesMilkbox Partners
Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
BiotechDeep TechHealthtechMunich, DE
Patrick Grossmann(CEO)inKilian Vogele(Founder)in
Co-investorsY Combinator10x Foundersanother.vcCapitalize VCPhoenix FundRicon GmbH
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ModelwiseProsperXterna
Frequently asked questions
- How many investments has Markovian made?
- Markovian has 5 tracked investments.
- What stage does Markovian invest at?
- Markovian invests at the Pre-Seed, Seed stages.
- What is Markovian's typical check size?
- Markovian typically writes checks of $50K.
- What sectors does Markovian focus on?
- Markovian focuses on AI & Machine Learning, Biotech, Cybersecurity, Deep Tech, Hardware, Healthtech, Medical Devices, Robotics, Semiconductors.
- Does Markovian lead rounds?
- Markovian typically participates in rounds rather than leading them.
- Who does Markovian co-invest with?
- Markovian most often shares deals with Fontinalis Partners, InMotion Ventures, Milkbox Partners, among 4 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Green Pine Capital Partners is a Chinese venture and technology investment firm with over two decades of history investing in technology companies, backing firms that have gone on to IPO.
Quad Ventures is a Korean venture capital firm that identifies founders driving lifestyle and industry change and invests in the technologies enabling them, backing early-stage startups across advanced technology sectors.
SATUS Venture is a Polish venture capital group based in Kraków that invests capital and expertise into early-stage, high-growth-potential companies. The group manages several seed and VC funds backed by around 100 private investors.
ZEISS Ventures is the corporate venture arm of the ZEISS Group, investing in and building deep tech start-ups whose innovations are relevant to ZEISS's strategic business units. It combines external venturing, internal venturing, and beyond-innovation activities.